In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Cabozantinib is a non-chemotherapy prescription medication classified as a tyros···【more】
Release date:2026-02-05Recommended:131
Patients should take pirfenidone with meals at a fixed time every day to reduce ···【more】
Release date:2026-02-04Recommended:166
The most common side effects of pirfenidone include upper respiratory tract infe···【more】
Release date:2026-02-04Recommended:130
Pirfenidone is an oral antifibrotic medication primarily used for the treatment ···【more】
Release date:2026-02-04Recommended:136
The safety of pirfenidone has been evaluated in more than 1,400 subjects, of who···【more】
Release date:2026-02-04Recommended:163
Nintedanib is a multi-targeted tyrosine kinase inhibitor; it can reduce the acti···【more】
Release date:2026-02-03Recommended:141
In 2019, nintedanib became the first therapy approved by the FDA to slow the rat···【more】
Release date:2026-02-03Recommended:164
Nintedanib is a small-molecule tyrosine kinase inhibitor that binds to growth fa···【more】
Release date:2026-02-03Recommended:133
Nintedanib is indicated for the treatment of diseases that cause scarring and ha···【more】
Release date:2026-02-03Recommended:144
Elacestrant is the world’s first approved oral selective estrogen receptor degra···【more】
Release date:2026-02-02Recommended:167
Before starting elacestrant, discuss any questions or concerns with your medical···【more】
Release date:2026-02-02Recommended:174
Take elacestrant daily and always follow the guidance of your medical team stric···【more】
Release date:2026-02-02Recommended:154